Lymphedema research conducted at Vanderbilt University Medical Center (VUMC) to better understand patient risk for this chronic condition and treatment responses received recognition at an international conference.

Vanderbilt researchers developed a new algorithm to find clinically targetable gene rearrangements in cancers.

Vanderbilt investigators have demonstrated that a certain protein complex drives tumor progression in aggressive breast cancers.

A new method developed at Vanderbilt may help “inventory” all tumor-promoting genes.

A targeted therapy for triple-negative breast cancer (TNBC), the most aggressive form of breast cancer, has shown potential promise in a recently published study. TNBC is the only type of breast cancer for which there are no currently approved targeted therapies.

Signaling by a receptor that is overexpressed in aggressive forms of breast cancer has been linked to glutamine metabolism, suggesting new anti-cancer therapeutic targets.

Pink will be the dominant color in Memorial Gymnasium Sunday, Feb. 14, as the Vanderbilt Commodores Women’s Basketball team participates in the annual Pink Out! game to raise awareness about breast cancer.